Editorial: Immunomodulatory role of metalloproteases in chronic inflammatory diseases.
作者信息
Yang Guan-Jun, Li Dan, Ko Chung Nga, Guo Shicheng, Yang Chao
机构信息
State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Ningbo University, Ningbo, Zhejiang, China.
Laboratory of Biochemistry and Molecular Biology, School of Marine Sciences, Ningbo University, Ningbo, China.
出版信息
Front Immunol. 2023 Apr 11;14:1196791. doi: 10.3389/fimmu.2023.1196791. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Immunomodulatory role of metalloproteases in chronic inflammatory diseases.
Front Immunol. 2023 Apr 11;14:1196791. doi: 10.3389/fimmu.2023.1196791. eCollection 2023.
2
Redefining metalloproteases specificity through network proteolysis.
Trends Mol Med. 2024 Feb;30(2):147-163. doi: 10.1016/j.molmed.2023.11.001. Epub 2023 Nov 29.
3
Metalloproteases and the degradome.
Methods Mol Biol. 2010;622:3-29. doi: 10.1007/978-1-60327-299-5_1.
4
Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications.
Curr Opin Pulm Med. 2011 Dec;17 Suppl 1:S11-9. doi: 10.1097/01.mcp.0000410743.98087.12.
5
Correlation of serum and urinary matrix metalloproteases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation.
Transpl Immunol. 2014 Jan;30(1):1-6. doi: 10.1016/j.trim.2013.11.004. Epub 2013 Nov 27.
6
Activity-Dependent Photoaffinity Labeling of Metalloproteases.
Methods Mol Biol. 2017;1491:103-111. doi: 10.1007/978-1-4939-6439-0_8.
7
Immunomodulatory role of metalloproteases in cancers: Current progress and future trends.
Front Immunol. 2022 Dec 16;13:1064033. doi: 10.3389/fimmu.2022.1064033. eCollection 2022.
8
Targeting matrix metalloproteases in diabetic wound healing.
Front Immunol. 2023 Feb 17;14:1089001. doi: 10.3389/fimmu.2023.1089001. eCollection 2023.
9
Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding.
Membranes (Basel). 2022 Feb 11;12(2):211. doi: 10.3390/membranes12020211.
10
Metalloproteases and inhibitors in arthritic diseases.
Best Pract Res Clin Rheumatol. 2001 Dec;15(5):805-29. doi: 10.1053/berh.2001.0195.
本文引用的文献
1
The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities.
Genes Dis. 2023 Mar 23;11(2):645-663. doi: 10.1016/j.gendis.2022.12.020. eCollection 2024 Mar.
2
The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy.
Bioorg Chem. 2023 Apr;133:106409. doi: 10.1016/j.bioorg.2023.106409. Epub 2023 Feb 4.
3
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review.
Oncogene. 2023 Feb;42(8):549-558. doi: 10.1038/s41388-022-02583-5. Epub 2022 Dec 26.
4
ITGB4 deficiency induces DNA damage by downregulating HDAC1 in airway epithelial cells under stress stimulation.
Pediatr Allergy Immunol. 2022 Oct;33(10):e13871. doi: 10.1111/pai.13871.
5
FRA1:c-JUN:HDAC1 complex down-regulates filaggrin expression upon TNFα and IFNγ stimulation in keratinocytes.
Proc Natl Acad Sci U S A. 2022 Sep 13;119(37):e2123451119. doi: 10.1073/pnas.2123451119. Epub 2022 Sep 6.
6
Nanocarriers for effective delivery: modulation of innate immunity for the management of infections and the associated complications.
J Nanobiotechnology. 2022 Aug 19;20(1):380. doi: 10.1186/s12951-022-01582-8.
7
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology.
Pharmacol Rev. 2022 Jul;74(3):712-768. doi: 10.1124/pharmrev.121.000349.
8
Discovery of natural product-like spirooxindole derivatives as highly potent and selective LSD1/KDM1A inhibitors for AML treatment.
Bioorg Chem. 2022 Mar;120:105596. doi: 10.1016/j.bioorg.2022.105596. Epub 2022 Jan 6.
9
A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid.
Biomolecules. 2021 Oct 13;11(10):1506. doi: 10.3390/biom11101506.
10
Pharmacological inhibition of KDM5A for cancer treatment.
Eur J Med Chem. 2021 Dec 15;226:113855. doi: 10.1016/j.ejmech.2021.113855. Epub 2021 Sep 15.
Zotero 插件